[{"address1": "260 Charles Street", "address2": "Suite 302", "city": "Waltham", "state": "MA", "zip": "02453", "country": "United States", "phone": "248-651-6568", "website": "https://www.optimizerx.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 135, "companyOfficers": [{"maxAge": 1, "name": "Mr. William J. Febbo", "age": 54, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 863150, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen L. Silvestro", "age": 45, "title": "President", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 591621, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edward  Stelmakh C.M.A., M.B.A.", "age": 57, "title": "CFO & COO", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 626738, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Jacob D'Silva", "title": "Senior Vice President of Corporate Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Marion K Odence-Ford", "age": 58, "title": "General Counsel & Chief Compliance Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 428117, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maira  Alejandra", "title": "Media Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sheryl  Kearney", "title": "Human Resources Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Terence J. Hamilton", "age": 58, "title": "Senior Vice President of Pharma", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 441632, "exercisedValue": 0, "unexercisedValue": 1068672}, {"maxAge": 1, "name": "Dr. Doug  Besch", "age": 41, "title": "Chief Product Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa  Greco", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.17, "open": 5.13, "dayLow": 4.97, "dayHigh": 5.25, "regularMarketPreviousClose": 5.17, "regularMarketOpen": 5.13, "regularMarketDayLow": 4.97, "regularMarketDayHigh": 5.25, "forwardPE": 14.089965, "volume": 217408, "regularMarketVolume": 217408, "averageVolume": 290219, "averageVolume10days": 366440, "averageDailyVolume10Day": 366440, "bid": 5.02, "ask": 5.12, "bidSize": 200, "askSize": 100, "marketCap": 93762384, "fiftyTwoWeekLow": 3.78, "fiftyTwoWeekHigh": 16.65, "priceToSalesTrailing12Months": 1.0633126, "fiftyDayAverage": 5.2754, "twoHundredDayAverage": 8.71635, "currency": "USD", "enterpriseValue": 118129912, "profitMargins": -0.27414, "floatShares": 15017354, "sharesOutstanding": 18420900, "sharesShort": 1001851, "sharesShortPriorMonth": 956303, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0544, "heldPercentInsiders": 0.13288, "heldPercentInstitutions": 0.68938005, "shortRatio": 2.7, "shortPercentOfFloat": 0.056799997, "impliedSharesOutstanding": 18321900, "bookValue": 5.703, "priceToBook": 0.89251274, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -24173866, "trailingEps": -1.34, "forwardEps": 0.49, "lastSplitFactor": "1:3", "lastSplitDate": 1526256000, "enterpriseToRevenue": 1.34, "enterpriseToEbitda": -35.441, "52WeekChange": -0.6374644, "SandP52WeekChange": 0.25891924, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "OPRX", "underlyingSymbol": "OPRX", "shortName": "OptimizeRx Corporation", "longName": "OptimizeRx Corporation", "firstTradeDateEpochUtc": 1196260200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "fa5dfbee-c9fe-3930-8f1d-3d3307c72117", "messageBoardId": "finmb_52289160", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.09, "targetHighPrice": 16.0, "targetLowPrice": 5.5, "targetMeanPrice": 9.78571, "targetMedianPrice": 8.0, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 16126000, "totalCashPerShare": 0.804, "ebitda": -3333187, "totalDebt": 35715000, "quickRatio": 2.932, "currentRatio": 3.234, "totalRevenue": 88179504, "debtToEquity": 31.202, "revenuePerShare": 4.863, "returnOnAssets": -0.03275, "returnOnEquity": -0.20969, "freeCashflow": 8347058, "operatingCashflow": -1566153, "revenueGrowth": 0.305, "grossMargins": 0.62595004, "ebitdaMargins": -0.0378, "operatingMargins": -0.05035, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-28"}]